Lonza and Doer Biologics in expression system license deal :

Lonza has signed a licensing agreement with clinical-stage biopharma, Zhejiang Doer Biologics, whereby the Hangzhou, China based biopharma company will develop multi-specific biotherapeutics using the Swiss CDMO’s XS Pichia.

Related Keywords

Yanshan Huang , Peter Droc , , Doer Biologics , Downstream Processing , Pipelines , Microbial Expression Systems , Monza , Dancer ,